Geode Capital Management
NERV icon

Geode Capital Management’s Minerva Neurosciences NERV Stock Holding History

Geode Capital Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.04M Buy
338,735
+268,816
+384% +$1.54M ﹤0.01% 3112
2025
Q4 		$281K Sell
69,919
-5,706
-8% -$21.2K ﹤0.01% 3797
2025
Q3 		$160K Hold
75,625
– – ﹤0.01% 3994
2025
Q2 		$130K Sell
75,625
-1,107
-1% -$1.81K ﹤0.01% 3999
2025
Q1 		$130K Buy
76,732
+20,276
+36% +$40K ﹤0.01% 3959
2024
Q4 		$125K Hold
56,456
– – ﹤0.01% 4041
2024
Q3 		$151K Buy
56,456
+1,345
+2% +$3.91K ﹤0.01% 3988
2024
Q2 		$176K Buy
55,111
+2,519
+5% +$6.82K ﹤0.01% 3960
2024
Q1 		$136K Buy
52,592
+500
+1% +$3.07K ﹤0.01% 4057
2023
Q4 		$320K Hold
52,092
– – ﹤0.01% 3773
2023
Q3 		$360K Buy
52,092
+128
+0.2% +$1.15K ﹤0.01% 3732
2023
Q2 		$475K Buy
51,964
+10,900
+27% +$57.6K ﹤0.01% 3661
2023
Q1 		$65.7K Hold
41,064
– – ﹤0.01% 4455
2022
Q4 		$65K Buy
41,064
+1,227
+3% +$5.3K ﹤0.01% 4521
2022
Q3 		$367K Hold
39,837
– – ﹤0.01% 3894
2022
Q2 		$131K Buy
39,837
+1,935
+5% +$7.91K ﹤0.01% 4476
2022
Q1 		$251K Sell
37,902
-21,979
-37% -$135K ﹤0.01% 4267
2021
Q4 		$383K Sell
59,881
-1,221
-2% -$11.5K ﹤0.01% 4175
2021
Q3 		$850K Buy
61,102
+5,380
+10% +$80.9K ﹤0.01% 3767
2021
Q2 		$1.03M Sell
55,722
-31,053
-36% -$668K ﹤0.01% 3579
2021
Q1 		$2.03M Buy
86,775
+9,572
+12% +$239K ﹤0.01% 3245
2020
Q4 		$1.45M Buy
77,203
+1,181
+2% +$29.7K ﹤0.01% 3236
2020
Q3 		$1.93M Buy
76,022
+7,733
+11% +$209K ﹤0.01% 2884
2020
Q2 		$1.97M Buy
68,289
+6,902
+11% +$405K ﹤0.01% 2848
2020
Q1 		$2.96M Buy
61,387
+3,882
+7% +$234K ﹤0.01% 2450
2019
Q4 		$3.27M Buy
57,505
+3,879
+7% +$171K ﹤0.01% 2714
2019
Q3 		$3.32M Buy
53,626
+2,628
+5% +$149K ﹤0.01% 2624
2019
Q2 		$2.3M Buy
50,998
+3,436
+7% +$172K ﹤0.01% 2856
2019
Q1 		$2.99M Buy
47,562
+2,835
+6% +$170K ﹤0.01% 2610
2018
Q4 		$2.41M Buy
44,727
+6,180
+16% +$452K ﹤0.01% 2663
2018
Q3 		$3.87M Buy
38,547
+1,404
+4% +$106K ﹤0.01% 2523
2018
Q2 		$2.45M Buy
37,143
+3,147
+9% +$191K ﹤0.01% 2739
2018
Q1 		$1.7M Buy
33,996
+226
+0.7% +$10.9K ﹤0.01% 2856
2017
Q4 		$1.63M Buy
33,770
+28
+0.1% +$1.39K ﹤0.01% 2871
2017
Q3 		$2.05M Buy
33,742
+12,887
+62% +$739K ﹤0.01% 2733
2017
Q2 		$1.48M Buy
20,855
+3,675
+21% +$238K ﹤0.01% 2902
2017
Q1 		$1.11M Buy
17,180
+1,251
+8% +$97.2K ﹤0.01% 2969
2016
Q4 		$1.5M Buy
15,929
+428
+3% +$43.7K ﹤0.01% 2792
2016
Q3 		$1.75M Buy
15,501
+3,035
+24% +$294K ﹤0.01% 2639
2016
Q2 		$1.02M Buy
12,466
+8,049
+182% +$512K ﹤0.01% 2896
2016
Q1 		$216 Buy
4,417
+481
+12% +$20.5K ﹤0.01% 3611
2015
Q4 		$191K Hold
3,936
– – ﹤0.01% 3700
2015
Q3 		$165K Hold
3,936
– – ﹤0.01% 3745
2015
Q2 		$182K Buy
3,936
+440
+13% +$18.8K ﹤0.01% 3615
2015
Q1 		$139K Hold
3,496
– – ﹤0.01% 3678
2014
Q4 		$168K Hold
3,496
– – ﹤0.01% 3643
2014
Q3 		$169K Buy
+3,496
New +$186K ﹤0.01% 3626

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM

Geode Capital Management's NERV Position: Q1 2026 in Review

Geode Capital Management increased its Minerva Neurosciences (NERV) stake by 384% in Q1 2026, buying an estimated $1.54M and bringing the position to 338,735 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3112.

Geode Capital Management first reported a position in NERV in Q3 2014 and has held it in 47 quarters since. The position peaked at $3.87M in Q3 2018. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Geode Capital Management held 338,735 shares of Minerva Neurosciences worth $2.04M as of Q1 2026.
  • Geode Capital Management bought 268,816 Minerva Neurosciences shares in Q1 2026, an estimated $1.54M.
  • Minerva Neurosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3112 holding.
  • Geode Capital Management first reported a position in Minerva Neurosciences in Q3 2014 and has held it in 47 quarters since.
  • Geode Capital Management's Minerva Neurosciences position peaked at $3.87M in Q3 2018.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.